Nima Motamed1, Behnam Rabiee2, Dhaya Perumal3, Hossein Poustchi4, Seyed Javad Haji Miresmail5, Behzad Farahani2, Mansooreh Maadi2, Fatemeh Sima Saeedian2, Hossein Ajdarkosh2, Mahmood Reza Khonsari2, Gholam Reza Hemasi2, Farhad Zamani6. 1. Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. 2. Gastrointestinal and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran. 3. Faculty of Science, Engineering and Computing, Kingston University, Kingston, United Kingdom. 4. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 5. Department of Cardiology, Hazrat Rasoul Hospital, Iran University of Medical Sciences, Tehran, Iran. 6. Gastrointestinal and Liver Disease Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran. Electronic address: zamani.farhad@gmail.com.
Abstract
BACKGROUND: Identification of individuals at risk of cardiovascular diseases (CVDs) results in better clinical outcomes and may help policy makers in conscious decision making for community based and national intervention strategies. The main aim of this study was to compare various CVD risk assessment tools and their related guidelines in estimation of 10-year CVD risk and subsequent therapeutic recommendations, respectively. METHODS: Data of 3086 subjects aged 40-74years from a cohort study of northern Iran were utilized in this cross-sectional study. The risks were calculated based on American College of Cardiology/American Heart Association (ACC/AHA) tool, two versions of Systematic Coronary Risk Evaluation (SCORE) equations (for low and high risk European countries) and Framingham approach. We also detected participants who ought to be recommended for treatment based on the specific guidelines related to each of the risk assessment tools. RESULTS: Mean cardiovascular risks were 12.96%, 8.84%, 1.90% and 3.45% in men and 5.87%, 2.13%, 0.8% and 1.13% in women based on ACC/AHA, Framingham, SCORE equation for low-risk European countries and high-risk European countries, respectively. Based on ACC/AHA, Adult Treatment Panel III (ATPIII) and European Society of Cardiology (ESC) guidelines related to SCORE equations for low and high risk European countries 58.2%, 27.1%, 21.1% and 28.6% of men and 39.7%, 33.0%, 29.5% and 30.7% of women were recommended to statin therapy, respectively. CONCLUSIONS: In conclusion, more individuals were recommended for treatment by ACC/AHA guideline than the other guidelines.
BACKGROUND: Identification of individuals at risk of cardiovascular diseases (CVDs) results in better clinical outcomes and may help policy makers in conscious decision making for community based and national intervention strategies. The main aim of this study was to compare various CVD risk assessment tools and their related guidelines in estimation of 10-year CVD risk and subsequent therapeutic recommendations, respectively. METHODS: Data of 3086 subjects aged 40-74years from a cohort study of northern Iran were utilized in this cross-sectional study. The risks were calculated based on American College of Cardiology/American Heart Association (ACC/AHA) tool, two versions of Systematic Coronary Risk Evaluation (SCORE) equations (for low and high risk European countries) and Framingham approach. We also detected participants who ought to be recommended for treatment based on the specific guidelines related to each of the risk assessment tools. RESULTS: Mean cardiovascular risks were 12.96%, 8.84%, 1.90% and 3.45% in men and 5.87%, 2.13%, 0.8% and 1.13% in women based on ACC/AHA, Framingham, SCORE equation for low-risk European countries and high-risk European countries, respectively. Based on ACC/AHA, Adult Treatment Panel III (ATPIII) and European Society of Cardiology (ESC) guidelines related to SCORE equations for low and high risk European countries 58.2%, 27.1%, 21.1% and 28.6% of men and 39.7%, 33.0%, 29.5% and 30.7% of women were recommended to statin therapy, respectively. CONCLUSIONS: In conclusion, more individuals were recommended for treatment by ACC/AHA guideline than the other guidelines.
Authors: Lily D Yan; Jean Lookens Pierre; Vanessa Rouzier; Michel Théard; Alexandra Apollon; Stephano St Preux; Justin R Kingery; Kenneth A Jamerson; Marie Deschamps; Jean W Pape; Monika M Safford; Margaret L McNairy Journal: BMC Public Health Date: 2022-03-19 Impact factor: 4.135
Authors: Jorge Zagaceta; Gorka Bastarrika; Javier J Zulueta; Inmaculada Colina; Ana B Alcaide; Arantza Campo; Miguel Divo; Ciro Casanova; José M Marin; Victor M Pinto-Plata; Bartolome R Celli; Juan P de-Torres Journal: Respir Res Date: 2017-09-29